Found 35 matching trials
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer PHASE2 This randomized phase II trial studies the side effects of durvalumab and t...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Learn More & Join Trial
Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases PHASE1 This study is evaluating the combination of Y-90 radioembolization followed...
Show More Location
Multiple Locations
Learn More & Join Trial
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma PHASE2 This phase II trial studies how well standard of care hypofractionated radi...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers PHASE1 This phase I trial studies how well stereotactic body radiation therapy wor...
Show More Location
UT Southwestern/Simmons Cancer Center-Dallas
Learn More & Join Trial
Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer PHASE2 This phase II trial studies how well durvalumab and tremelimumab work in tr...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer PHASE1 The purpose of this study is to determine if MEDI4736 will be adequately to...
Show More Learn More & Join Trial
Oral Decitabine (ASTX727) and Durvalumab in Recurrent and/or Metastatic Head and Neck Cancer Patients PHASE1 This is a non-randomized, open-label, Phase Ib study to assess the safety a...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer PHASE3 This is a randomized, open-label, multi-center, 3-arm, global Phase III stu...
Show More Learn More & Join Trial
Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer PHASE1 This is an open-label, three-cohort, phase Ib study to determine the safety...
Show More Location
Georgetown University Medical Center
Learn More & Join Trial
MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBCL (D4190C00023) PHASE1 The purpose of this study is to evaluate the safety, tolerability, and effi...
Show More Learn More & Join Trial